HCV reinfection incidence among individuals treated for recent infection
M Martinello, J Grebely, K Petoumenos, E Gane, M Hellard, D Shaw, J Sasadeusz, TL Applegate, GJ Dore, GV Matthews
Journal of Viral Hepatitis | WILEY | Published : 2017
Awarded by National Institute on Drug Abuse of the National Institutes of Health
The Kirby Institute is funded by the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. The Burnet Institute receives funding from the Victorian Operational Infrastructure Support Program. Research reported in this publication was supported by the National Institute on Drug Abuse of the National Institutes of Health (R01DA015999), Janssen-Cilag Pty Ltd and Gilead Sciences Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Jason Grebely and Gail Matthews are supported through NHMRC Career Development Fellowships. Gregory Dore is supported through NHMRC Practitioner Fellowships. None of the authors has commercial relationships that might pose a conflict of interest in connection with this manuscript.